Cargando…
Correction to: The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study
Autores principales: | Fraser, Simon D. S., Roderick, Paul J., May, Carl R., McIntyre, Natasha, McIntyre, Christopher, Fluck, Richard J., Shardlow, Adam, Taal, Maarten W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754571/ https://www.ncbi.nlm.nih.gov/pubmed/33349233 http://dx.doi.org/10.1186/s12882-020-02205-w |
Ejemplares similares
-
The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study
por: Fraser, Simon D. S., et al.
Publicado: (2015) -
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3
por: Shardlow, Adam, et al.
Publicado: (2017) -
Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study
por: Fraser, Simon DS, et al.
Publicado: (2020) -
Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study
por: Shardlow, Adam, et al.
Publicado: (2016) -
The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study
por: Shardlow, Adam, et al.
Publicado: (2017)